![Rainer Fischer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rainer Fischer
Direktor/Vorstandsmitglied bei Indiana Biosciences Research Institute
Aktive Positionen von Rainer Fischer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Indiana Biosciences Research Institute
![]() Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services The Indiana Biosciences Research Institute is a biomedical research organization that aims to solve challenging health problems and improve patient outcomes. The Eli Lilly and Company Diabetes Center of Excellence, located at the institute, is dedicated to studying the molecular basis of diabetes and its complications. The non-profit company is based in Indianapolis, IN. The company's research focuses on translating disease hypotheses into potential therapies. Alan Palkowitz has been the CEO of the company since 2020. | Direktor/Vorstandsmitglied | - | - |
Corporate Officer/Principal | 19.04.2019 | - | |
Vorstandsvorsitzender | 01.10.2017 | 19.04.2019 | |
Technik-/Wissenschafts-/F&E-Leiter | 01.10.2016 | 19.04.2019 |
Karriereverlauf von Rainer Fischer
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Indiana Biosciences Research Institute
![]() Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services The Indiana Biosciences Research Institute is a biomedical research organization that aims to solve challenging health problems and improve patient outcomes. The Eli Lilly and Company Diabetes Center of Excellence, located at the institute, is dedicated to studying the molecular basis of diabetes and its complications. The non-profit company is based in Indianapolis, IN. The company's research focuses on translating disease hypotheses into potential therapies. Alan Palkowitz has been the CEO of the company since 2020. | Commercial Services |
- Börse
- Insiders
- Rainer Fischer
- Erfahrung